{"id":987123,"date":"2026-07-30T07:22:12","date_gmt":"2026-07-30T11:22:12","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/"},"modified":"2026-07-30T07:22:12","modified_gmt":"2026-07-30T11:22:12","slug":"evogene-schedules-second-quarter-2026-financial-results-release","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/","title":{"rendered":"Evogene Schedules Second Quarter 2026 Financial Results Release"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p class=\"prntac\">\n        <i>Zoom conference call scheduled for August 18, 2026, 9:00 AM ET<\/i>\n      <\/p>\n<p>\n        <span class=\"legendSpanClass\">REHOVOT, Israel<\/span>, <span class=\"legendSpanClass\">July 30, 2026<\/span> \/PRNewswire\/ &#8212; <b>Evogene Ltd<\/b>. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the second quarter 2026, on <b>Tuesday<\/b><b>, <\/b><b>August 18<\/b><b>, 2026<\/b>.<\/p>\n<div id=\"prni_dvprnejpg4f51left\" dir=\"ltr\" style=\"width: 100%;text-align: left\">\n        <img decoding=\"async\" id=\"prnejpg4f51left\" style=\"width: 400px;height: 133px\" title=\"Evogene Logo\" src=\"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg\" alt=\"Evogene Logo\" align=\"middle\" \/>\n      <\/div>\n<p>Later that day, company management will host a <b>conference call to discuss the results at 9:00 AM Eastern Time<\/b> (4:00 PM Israel time).<\/p>\n<p>To attend the conference, please register in advance:<\/p>\n<p>\n        <a href=\"https:\/\/www.veidan-conferencing.com\/evogene\" target=\"_blank\" rel=\"nofollow\">https:\/\/www.veidan-conferencing.com\/evogene<\/a>\n      <\/p>\n<p>The entire conference will be available online on the company&#8217;s website a few days after.<\/p>\n<p>\n        <b>About Evogene:<\/b>\n      <\/p>\n<p>Evogene Ltd.\u00a0(Nasdaq: EVGN) (TASE: EVGN) is a pioneering company in computational chemistry, specializing in the generative design of small molecules for drug development and ag chemical products. At the core of its technology is <i>ChemPass AI\u2122<\/i>, a proprietary generative AI designed to explore vast chemical space and generate novel, highly potent small molecules optimized across multiple critical parameters.\u00a0Built on this powerful technological foundation, and through strategic partnerships alongside internal product development, Evogene is focused on creating breakthrough products for the pharmaceutical and agricultural industries, driven by the integration of scientific innovation with real-world industry needs.<\/p>\n<p>For more information, please visit <a href=\"https:\/\/www.evogene.com\/\" target=\"_blank\" rel=\"nofollow\">www.evogene.com<\/a>.<\/p>\n<p>\n        <b>Contact<\/b>\n      <\/p>\n<p>\n        <a href=\"mailto:ir@evogene.com\" target=\"_blank\" rel=\"nofollow\">ir@evogene.com<\/a><br \/>\n        <br \/>\n        <span>Tel: +972-8-9311901<\/span>\n      <\/p>\n<p>\n        <span>Logo &#8211; <a href=\"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg\" target=\"_blank\" rel=\"nofollow\">https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg<\/a>\u00a0<\/span>\n      <\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/edge.prnewswire.com\/c\/img\/favicon.png?sn=LN15823&amp;sd=2026-07-30\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/evogene-schedules-second-quarter-2026-financial-results-release-302838854.html<\/a><\/p>\n<p>SOURCE Evogene<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=LN15823&amp;Transmission_Id=202607300700PR_NEWS_USPR_____LN15823&amp;DateId=20260730\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the second quarter 2026, on Tuesday, August 18, 2026. Later that day, company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conference, please register in advance: https:\/\/www.veidan-conferencing.com\/evogene The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd.\u00a0(Nasdaq: EVGN) (TASE: EVGN) is &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Evogene Schedules Second Quarter 2026 Financial Results Release&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-987123","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.1 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the second quarter 2026, on Tuesday, August 18, 2026. Later that day, company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conference, please register in advance: https:\/\/www.veidan-conferencing.com\/evogene The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd.\u00a0(Nasdaq: EVGN) (TASE: EVGN) is &hellip; Continue reading &quot;Evogene Schedules Second Quarter 2026 Financial Results Release&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-30T11:22:12+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Evogene Schedules Second Quarter 2026 Financial Results Release\",\"datePublished\":\"2026-07-30T11:22:12+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/\"},\"wordCount\":250,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2814604\\\/Evogene_Logo.jpg\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/\",\"name\":\"Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2814604\\\/Evogene_Logo.jpg\",\"datePublished\":\"2026-07-30T11:22:12+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2814604\\\/Evogene_Logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mma.prnewswire.com\\\/media\\\/2814604\\\/Evogene_Logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/evogene-schedules-second-quarter-2026-financial-results-release\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Evogene Schedules Second Quarter 2026 Financial Results Release\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/","og_locale":"en_US","og_type":"article","og_title":"Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk","og_description":"PR Newswire Zoom conference call scheduled for August 18, 2026, 9:00 AM ET REHOVOT, Israel, July 30, 2026 \/PRNewswire\/ &#8212; Evogene Ltd. (Nasdaq: EVGN) (TASE: EVGN), a pioneering company in computational chemistry, specializing in the generative design of small molecules for the pharmaceutical and agricultural industries, announced today that it will release its financial results for the second quarter 2026, on Tuesday, August 18, 2026. Later that day, company management will host a conference call to discuss the results at 9:00 AM Eastern Time (4:00 PM Israel time). To attend the conference, please register in advance: https:\/\/www.veidan-conferencing.com\/evogene The entire conference will be available online on the company&#8217;s website a few days after. About Evogene: Evogene Ltd.\u00a0(Nasdaq: EVGN) (TASE: EVGN) is &hellip; Continue reading \"Evogene Schedules Second Quarter 2026 Financial Results Release\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/","og_site_name":"Market Newsdesk","article_published_time":"2026-07-30T11:22:12+00:00","og_image":[{"url":"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Evogene Schedules Second Quarter 2026 Financial Results Release","datePublished":"2026-07-30T11:22:12+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/"},"wordCount":250,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/","name":"Evogene Schedules Second Quarter 2026 Financial Results Release - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#primaryimage"},"thumbnailUrl":"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg","datePublished":"2026-07-30T11:22:12+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#primaryimage","url":"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg","contentUrl":"https:\/\/mma.prnewswire.com\/media\/2814604\/Evogene_Logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/evogene-schedules-second-quarter-2026-financial-results-release\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Evogene Schedules Second Quarter 2026 Financial Results Release"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987123","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=987123"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/987123\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=987123"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=987123"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=987123"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}